Sat.Dec 04, 2021 - Fri.Dec 10, 2021

article thumbnail

Digital health firm Pear goes public, raising $175 million

pharmaphorum

Pear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing and raising $175 million in gross proceeds for the digital health specialist. Pear will make its debut on the exchange today after combining with Thimble Point – a special purpose acquisition company (SPAC) – in a deal that sidestepped the conventional initial public offering (IPO) route and has propelled its valuation to around $1.6 billion.

FDA 133
article thumbnail

Is artificial intelligence the best tool for drug discovery?

Outsourcing Pharma

According to a leader from Cytoreason, AI isnât necessarily the best or only tool suited to discover new and novel therapiesâit might take a human touch.

144
144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amazon launches new elder care subscription service Alexa Together with emergency assistance, fall detection

Fierce Healthcare

Amazon launches new elder care subscription service Alexa Together with emergency assistance, fall detection. rtorrence. Wed, 12/08/2021 - 11:21.

131
131
article thumbnail

HER2 Targeting Therapies Market: A Deeper Look into Therapy Developer Landscape and Future Opportunities

Roots Analysis

The epidermal growth factor receptor (EGFR is a tumor resistance biomarker which plays an essential role in the differentiation and proliferation upon activation through the binding of one of its ligands. A non-ligand-binding member of EGFR family, HER2 exerts its activity through heterodimerisation along with its other family members. HER2 is a transmembrane growth factor receptor present in the normal and malignant breast epithelial cells.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

AI-based drug discovery firm BenevolentAI cuts SPAC deal

pharmaphorum

UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal. BenevolentAI will merge with Odyssey Acquisition, a SPAC set up by investment bankers Michael and Yoel Zaoui that lists former Sanofi chief executive Olivier Brandicourt among its advisors – in a deal that will raise some €390 million in proceeds.

FDA 119
article thumbnail

Deloitte, PhRMA join forces on clinical trial diversity report

Outsourcing Pharma

The organizations have issued an in-depth look on issues impacting inclusivity, why change is needed, and potential solutions for increasing trial diversity.

88

More Trending

article thumbnail

Rita Ribeiro

Pharma Marketing Network

Rita Ribeiro, Product Director, Oncology Marketing, is a marketing leader with 20 years of global and US healthcare experience in pharmaceutical, medical device and services organizations. She has developed and implemented regionalized, integrated strategic plans to increase brand awareness and drive organizational growth across multiple therapeutic areas and service networks.

52
article thumbnail

Consumer health innovation – where passion and science meet

pharmaphorum

Heather Barnes, external innovation lead EMEA at Johnson and Johnson Consumer Health, is a scientist who is truly passionate about consumer health. With her background in biochemistry and eye for identifying innovation trends, the future is bright at Johnson & Johnson Innovation. After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families.

Packaging 105
article thumbnail

Roquette plans to open doors of new US innovation center

Outsourcing Pharma

Sited in Pennsylvania, the excipients specialistâs new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

59
article thumbnail

Health services M&A deals surged in 2021. Here are key trends that could impact deal-making next year, PwC reports

Fierce Healthcare

Health services M&A deals surged in 2021. Here are key trends that could impact deal-making next year, PwC reports. hlandi. Fri, 12/10/2021 - 14:55.

126
126
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

THE RISING REALM: BIOPRESERVATION MEDIA INDUSTRY

Roots Analysis

Biopreservation is the exclusive biological approach designated for the preservation of cells, tissues and organs ex-vivo for the purpose of storage, shipment and transportation. Biopreservation media is one of the most crucial entity in conferring effectiveness. The selection of the type of media depends upon the considerable time duration desired for the storage, type of biological material to be preserved and the purpose of biopreservation.

article thumbnail

Mind the gap: Are you delivering what HCPs value or what you want them to have?

pharmaphorum

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). In the age of information overload, we all know that it is essential to add ‘value’ if we are to cut through the noise. And therein lies an issue. In a recent study by EPG Health, pharma respondents voted ‘providing real value’ the top challenge (of 23) related to digital Health Care Provider (HCP) engagement.

article thumbnail

Abu Dhabi to Strengthen its Capabilities as a Life Sciences Hub Through a Pharma Collaboration with Belgium

Pharma Mirror

UAE, Abu Dhabi , Abu Dhabi has set its sights on Belgium, as a leading global pharmaceutical hub, to establish a global distribution corridor to serve the world in vaccine delivery and future life science needs. The collaboration builds on the capabilities of Abu Dhabi’s healthcare sector as a leading life sciences hub and the efforts of the HOPE Consortium in providing vaccine solutions for the world.

article thumbnail

SAMSHA offers $30M in grants to boost harm reduction strategies to curb opioid abuse

Fierce Healthcare

SAMSHA offers $30M in grants to boost harm reduction strategies to curb opioid abuse. rking. Wed, 12/08/2021 - 13:33.

136
136
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Top 7 Questions about Psychedelics and Pharmacy

The Spirit Pharmacist

7 Questions about Psychedelics and the Pharmacist. Friends, pharmacists, and media often ask me questions about psychedelics and pharmacy or psychedelic and the role of the pharmacist. So I thought to compile a list of 7 commonly ask questions and answer them! Take a look below or watch the video above to get my thoughts on these important questions relating to psychedelics and pharmacist. 1.

article thumbnail

AbbVie prices first presbyopia drug Vuity at $80 per month

pharmaphorum

AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects. The company told CBS it will charge around $80 for a 30-day supply of Vuity , a once-daily eyedrop formulation of muscarinic cholinergic agonist pilocarpine intended as an alternative to reading glasses, contact lenses or laser eye surgery.

article thumbnail

Distributed Control System Facilitates Expansion for New Drugs Produced by Contract Manufacturing Organization

Pharma Mirror

Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up. For example, to meet the urgent need for COVID-19 related therapies and vaccines early in the pandemic, Thermo Fisher Scientific, a world leader in serving science with annual revenue of approximately $35 billion, had to expand its

article thumbnail

Providers still skeptical about wearable accuracy, integration abilities

Fierce Healthcare

Providers still skeptical about wearable accuracy, integration abilities. rtorrence. Mon, 12/06/2021 - 14:10.

140
140
article thumbnail

Pharmaceutical Education Policy

Pharma Tutor

Pharmaceutical Education Policy. About Author. Dr. R. S. Thakur. Chief Editor. Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy. Bengaluru-560035. admin. Tue, 12/07/2021 - 17:15. Tags. Articles.

52
article thumbnail

Intercept’s travails continue as it pulls NASH drug filing in EU

pharmaphorum

Already scrambling to refile its obeticholic acid (OCA) drug for non-alcoholic steatohepatitis (NASH) after the FDA rejected it last year, Intercept Pharma was hoping for more luck in Europe, but has now withdrawn its EU marketing application. Intercept had been hoping to extend the review period in the EU to allow time for results from an ongoing to phase 3 trial to come in, now due in the first quarter of next year, but conceded defeat yesterday.

article thumbnail

Business & Industry Research

Fuld

Business & Industry Research. Our business and industry research offerings help clients make more informed and effective decisions. From conducting detailed market due diligence procedures to meeting urgent data requirements, our research services support all business processes, client sectors, and geographical areas. To ensure our customers optimize their competitive position, we offer highly customized and actionable research insights addressing specific business problems and organizationa

52
article thumbnail

Anthem-backed Hydrogen Health rolls out virtual primary care services for insurers, employers

Fierce Healthcare

Anthem-backed Hydrogen Health rolls out virtual primary care services for insurers, employers. hlandi. Thu, 12/09/2021 - 09:01.

Insurance 130
article thumbnail

Tap Native Unveils the Top 20 Most Popular Health Topics of 2021

Pharma Marketing Network

Direct Integrations with hundreds of leading health websites provides Tap Native access to billions of content pages for analysis. NEW YORK, December 6 th , 2021 (PRNEWSWIRE) – Tap Native, the leading health-focused content discovery platform, today unveiled a list of the top 20 most popular health topics viewed by consumer audiences in 2021. Tap Native analyzed visits to health and medical content pages across dozens of health websites where consumers seek answers to their most important health

article thumbnail

Omicron may evade Pfizer/BioNTech COVID jab, says study

pharmaphorum

Preliminary study results from South Africa have suggested that antibodies stimulated by Pfizer and BioNTech’s Comirnaty are less effective against the new COVID-19 variant Omicron. A study by the African Health Research Institute (AHRI) has found that the less of immune protection was “extensive but incomplete,” meaning that some level of immunity was retained against the vaccine.

article thumbnail

Plum for Skin, Hair & Healthcare

Pharma Tutor

Plum for Skin, Hair & Healthcare. About Authors. Monika Chamoli 1 , Upma Singh 2 , Raaz K. Maheshwari 3 *. 1 Department of Applied Sciences, Pt LR College of Technology, Faridabad, Haryana. 2 Department of Applied Chemistry, School of Vocational Studies & Applied Sciences, Gautam Buddha University, Gautam Buddha Nagar, Greater Noida, UP. 3 Department of Chemistry, SBRM Govt PG College, Nagaur, Rajasthan.

52
article thumbnail

From 340B to short-term health plans: Here are the top 4 regulations to watch for in 2022

Fierce Healthcare

From 340B to short-term health plans: Here are the top 4 regulations to watch for in 2022. rking. Fri, 12/10/2021 - 16:44.

132
132
article thumbnail

Survey: research industry keen on DCT benefits, slow to adopt

Outsourcing Pharma

A survey on perceptions toward the decentralized clinical trial format, conducted by Climedo, shows the industry is aware of the benefits but faces barriers.

52
article thumbnail

Seizing opportunities with perfectly pitched messages

pharmaphorum

Personal relationships have been the dominant force in sales for generations but the pandemic has ripped up this conveyer belt of convenience. More than 60% of clinicians are happy to either connect solely via technology or via a hybrid arrangement and there is no going back. The pharmaceutical industry became stuck in a groove of letting doctor-rep relationships obscure the challenge of delivering complex information in perfectly pitched presentations.

article thumbnail

Cancer clinical trial recruitment drops by 60% during pandemic

Pharma Times

In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from clinicians and patients aims to provide guidance on how to improve services

51
article thumbnail

Robin Healthcare lands $50M for its 'Alexa for healthcare' scribe device that takes over administrative tasks

Fierce Healthcare

Robin Healthcare lands $50M for its 'Alexa for healthcare' scribe device that takes over administrative tasks. rtorrence. Tue, 12/07/2021 - 10:15.

119
119
article thumbnail

Time to take trial data analysis to the next level: ConcertAI

Outsourcing Pharma

A leader from the advanced data and artificial intelligence specialist suggests ways to advance data collection through new tools, techniques, and thinking.

52
article thumbnail

HypnoVR raises €4.5m for its digital sedative for pain, anxiety

pharmaphorum

French digital health startup HypnoVR has completed a first-round financing, raising €4.5 million ($5.1 million) that will be used to roll out its virtual reality-based hypnosis therapies. The company has developed a an individually tailored immersive VR platform that it uses to deliver clinical hypnosis techniques to alleviate chronic pain, anxiety and discomfort during medical procedures like surgery.

article thumbnail

Pet Peeves With Urinary Issues

Med Ed 101

I encounter patients on a daily basis who are taking medications for urinary issues. Incontinence, frequency, BPH, and frequent UTIs are common problems in geriatrics that can lead to the use of medications. Here are some of my pet peeves with these issues. No One Ever Reassesses OAB Medications Patients who get placed on medications […]. The post Pet Peeves With Urinary Issues appeared first on Med Ed 101.

40
article thumbnail

Centene to pay $27.6M to settle PBM investigation in Kansas

Fierce Healthcare

Centene to pay $27.6M to settle PBM investigation in Kansas. pminemyer. Tue, 12/07/2021 - 12:52.

145
145